ScienceAlert on MSN
World first: Patient receives high-risk therapy to make cells young again
(Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the ...
Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...
Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities ...
New research suggests that paralyzed patients could regain some degree of movement — perhaps even walk again. In a study led by EPFL (Swiss Federal Technology Institute of Lausanne) and Lausanne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results